Susquehanna International Group’s OKYO Pharma OKYO Stock Holding History

Susquehanna International Group’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,123	Closed	-$13.6K	–	12730
2024 Q2	$13.6K	Sell	11,123 -9,187	-45%	-$12.9K	﹤0.01%	11732
2024 Q1	$30.5K	Sell	20,310 -14,474	-42%	-$22.2K	﹤0.01%	11715
2023 Q4	$61.9K	Buy	+34,784	New	+$61.1K	﹤0.01%	11621

Other funds holding OKYO

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's OKYO Position: Q3 2024 in Review

Susquehanna International Group sold out of OKYO Pharma (OKYO) in Q3 2024, closing a stake of 11,123 shares — an estimated $13.6K sold.

Susquehanna International Group first reported a position in OKYO in Q4 2023 and held it in 3 quarters. The position peaked at $61.9K in Q4 2023. 6 funds tracked by Wall St. Rank hold OKYO as of Q3 2024.

Susquehanna International Group reported no remaining OKYO Pharma position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 11,123 OKYO Pharma shares in Q3 2024, an estimated $13.6K.
Susquehanna International Group first reported a position in OKYO Pharma in Q4 2023 and held it in 3 quarters.
Susquehanna International Group's OKYO Pharma position peaked at $61.9K in Q4 2023.
6 funds tracked by Wall St. Rank held OKYO Pharma as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.